Diabetic Peripheral Neuropathy and Impotence: A Cross-Sectional Analysis

Authors

  • Lubna Meraj Department of Medicine, Benazir Bhutto Hospital, Rawalpindi Medical University, Rawalpindi, Pakistan. Author
  • Zia Ullah Khan Sir Syed College of Medical Sciences Karachi, Pakistan. Author
  • Abida Mateen Bahria University College of Medicine, Pakistan. Author
  • Saira Bashir Department of Diabetes Endocrinology, Federal Government Polyclinic Hospital Islamabad, Pakistan. Author
  • Hina Azeez Department of General Medicine, Federal Government Polyclinic Hospital Islamabad, Pakistan. Author
  • Arzu Yousuf Department of Urology, Razi Alkhidmat Hospital, Rawalpindi, Pakistan Author
  • Usman Wajid University Institute of Biochemistry and Biotechnology, Pir Mehr Ali Shah Arid Agriculture University Rawalpindi Author

DOI:

https://doi.org/10.48047/HM.10.2.2024.1325-1330

Keywords:

Peripheral neuropathy, Impotence, type-II diabetes.

Abstract

To observe the association of Impotence in patients with type 2 Diabetes Mellitus presenting with peripheral neuropathy.

Methodology:

The Department of Medicine at Benazir Bhutto Hospital in Rawalpindi conducted this cross-sectional study between May 2023 and June 2024. Upon obtaining written informed consent, all male participants with type 2 diabetes who were diagnosed with peripheral neuropathy and aged between 35 and 65 were included in the study. To diagnose and gauge the severity of erectile dysfunction, the local language version of the IIEF-5 questionnaire—Urdu—was utilized. The data analysis was done using SPSS version 20.

Results:

A total of 112 males with type 2 diabetes were recruited in this study. The mean age was 59.25±5.12 years, the mean diabetes duration of 9.9±4.81 years, and the mean HbA1c was found 9.01±2.10% respectively. The mean IIEF-5 Score was 12.41±5.99 and in regard to the severity of Impotence among study participants, 28(19%) fell in severe erectile dysfunction, 21(18%) in moderate erectile dysfunction, and 34(30.7%) in moderate to mild erectile dysfunction. Impotence status showed a statistically significant association with an increase duration of diabetes having p-value of <0.05, whereas age and HbA1c revealed a statistically insignificant association.

Conclusion:

When type 2 diabetic individuals with peripheral neuropathy manifest, Impotencies common among them. To confirm the study's conclusions, further extensive, community-based research will be needed.

Downloads

Download data is not yet available.

References

Malavige LS, Levy JC. Impotencein diabetes mellitus. The journal of sexual medicine. 2009 May;6(5):1232-47. DOI: 10.1111/j.1743-6109.2008.01168.x

Furukawa S, Sakai T, Niiya T, Miyaoka H, Miyake T, Yamamoto S, et al. Diabetic peripheral neuropathy and prevalence of Impotencein Japanese patients aged< 65 years with type 2 diabetes mellitus: The Dogo Study. International Journal of Impotence Research. 2017 Jan;29(1):30-4. DOI: 10.1038/ijir.2016.40

Binmoammar TA, Hassounah S, Alsaad S, Rawaf S, Majeed A. The impact of poor glycaemic control on the prevalence of Impotencein men with type 2 diabetes mellitus: a systematic review. JRSM open. 2016 Feb 12;7(3):2054270415622602. DOI: 10.1177/2054270415622602

Sun J, Wang Y, Zhang X, Zhu S, He H. Prevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis. Primary care diabetes. 2020 Oct 1;14(5):435-44. DOI: 10.1016/j.pcd.2019.12.005

Kouidrat Y, Pizzol D, Cosco T, Thompson T, Carnaghi M, Bertoldo A, et al. High prevalence of Impotencein diabetes: a systematic review and meta‐analysis of 145 studies. Diabetic Medicine. 2017 Sep;34(9):1185-92. DOI: 10.1111/dme.13403

Defeudis G, Gianfrilli D, Di Emidio C, Pofi R, Tuccinardi D, Palermo A, et al. Impotenceand its management in patients with diabetes mellitus. Reviews in Endocrine and Metabolic Disorders. 2015 Sep;16:213-31. DOI: 10.1007/s11154-015-9321-4

Løseth S, Stålberg EV, Lindal S, Olsen E, Jorde R, Mellgren SI. Small and large fiber neuropathy in those with type 1 and type 2 diabetes: a 5‐year follow‐up study. Journal of the Peripheral Nervous System. 2016 Mar;21(1):15-21. DOI: 10.1111/jns.12154

Raheem OA, Su JJ, Wilson JR, Hsieh TC. The association of Impotenceand cardiovascular disease: a systematic critical review. American journal of men's health. 2017 May;11(3):552-63. DOI: 10.1177/1557988316630305

Maffei L, Premrou V, Roldan P, Copetti M, Pellegrini F, Rossi MC, et al. Vibration perception threshold in the screening of sensorimotor distal symmetric polyneuropathy: the need of more accurate age-specific reference values. Journal of diabetes science and technology. 2014 May;8(3):621-2. doi: 10.1177/1932296814527818

Defeudis G, Mazzilli R, Tenuta M, Rossini G, Zamponi V, Olana S, et al. Impotenceand diabetes: A melting pot of circumstances and treatments. Diabetes/Metabolism Research and Reviews. 2022 Feb;38(2):e3494. DOI: 10.1002/dmrr.3494

Singh P, Arora S, Goyal A, Mittal N, Singh A, Sharma S, et al. INFLUENCE OF THE DURATION OF DIABETES AND VIBRATION PERCEPTION THRESHOLD ON THE SEVERITY OF IMPOTENCEIN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Acta Endocrinologica (Bucharest). 2022 Apr;18(2):174. doi: 10.4183/aeb.2022.174

Sasaki H, Yamasaki H, Ogawa K, Nanjo K, Kawamori R, Iwamoto Y, et al. Prevalence and risk factors for Impotencein Japanese diabetics. Diabetes research and clinical practice. 2005 Oct 1;70(1):81-9. DOI: 10.1016/j.diabres.2005.02.018

Mahmood MA, Rehman KU, Khan MA, Sultan T. Translation, cross-cultural adaptation, and psychometric validation of the 5-item International Index of Erectile Function (IIEF-5) into Urdu. The Journal of Sexual Medicine. 2012 Jul;9(7):1883-6. DOI: 10.1111/j.1743-6109.2012.02714.x

Himeno T, Kamiya H, Nakamura J. Lumos for the long trail: Strategies for clinical diagnosis and severity staging for diabetic polyneuropathy and future directions. Journal of Diabetes Investigation. 2020 Jan;11(1):5-16. doi: 10.1111/jdi.13173

Medakkel AA, Sheela P. Vibration Perception Threshold Values and Clinical Symptoms of Diabetic Peripheral Neuropathy. Journal of Clinical & Diagnostic Research. 2018 May 1;12(5). DOI: 10.7860/JCDR/2018/32825.11549

GoyAl A, SinGh P, AhUjA A. Prevalence and severity of Impotenceas assessed by IIEF-5 in North Indian type 2 diabetic males and its correlation with variables. Journal of clinical and diagnostic research: JCDR. 2013 Dec;7(12):2936. doi: 10.7860/JCDR/2013/7718.3777

Defeudis G, Di Tommaso AM, Di Rosa C, Cimadomo D, Khazrai YM, Faggiano A, et al. The role of antihyperglycemic drugs and diet on erectile function: results from a perspective study on a population with prediabetes and diabetes. Journal of Clinical Medicine. 2022 Jun 13;11(12):3382. doi: 10.3390/jcm11123382

Ghanem YM, Zahran AR, Younan DN, Zeitoun MH, El Feky AY. Prevalence of Impotenceamong Egyptian male patients with type 2 diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021 May 1;15(3):949-53. DOI: 10.1016/j.dsx.2021.04.019

Gandaglia G, Briganti A, Jackson G, Kloner RA, Montorsi F, Montorsi P, et al. A systematic review of the association between Impotenceand cardiovascular disease. European urology. 2014 May 1;65(5):968-78. DOI: 10.1016/j.eururo.2013.08.02#

Wajid, Usman, Ahmed Haider, Toaqeer Salman, Muhammad Luqman, and Paris Anwar. "Assessment and Relationship of Elevated Serum Alanine Transaminase Level in Reference with Obesity." Journal of Pharmaceutical Research International 35, no. 15 (2023): 24-35. DOI: 10.9734/jpri/2023/v35i157374

Downloads

Published

2024-04-30

How to Cite

Meraj, L., Ullah Khan, Z., Mateen, A., Bashir, S., Azeez, H., Yousuf, A., & Wajid, U. (2024). Diabetic Peripheral Neuropathy and Impotence: A Cross-Sectional Analysis. History of Medicine, 10(2), 1325-1330. https://doi.org/10.48047/HM.10.2.2024.1325-1330